The trademark application Opfolda was filed by Amicus Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 24, 2021, and it was registered by office on June 3, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 27, 2021. Creation of rights in rem of the trademark registration was recorded on January 29, 2024.